Q2 EPS Forecast for Tenax Therapeutics Reduced by Analyst
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities research analysts at William Blair lowered their Q2 2025 EPS estimates for Tenax Therapeutics in a report released on Wednesday, May 14th. William Blair analyst M. Phipps now anticipates that the specialty pharmaceutical company will earn ($0.24) per share for the quarter, down from their previous […]
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities research analysts at William Blair lowered their Q2 2025 EPS estimates for Tenax Therapeutics in a report released on Wednesday, May 14th. William Blair analyst M. Phipps now anticipates that the specialty pharmaceutical company will earn ($0.24) per share for the quarter, down from their previous […]
